Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils

被引:914
|
作者
Ahmed, Mahiuddin [1 ]
Davis, Judianne [2 ]
Aucoin, Darryl [1 ]
Sato, Takeshi [3 ]
Ahuja, Shivani [4 ]
Aimoto, Saburo [3 ]
Elliott, James I. [5 ]
Van Nostrand, William E. [2 ]
Smith, Steven O. [1 ]
机构
[1] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA
[3] Osaka Univ, Inst Prot Res, Osaka, Japan
[4] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA
[5] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
ASSISTED ROTATIONAL RESONANCE; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; AGGREGATION PROPERTIES; PROTEIN; PEPTIDE; A-BETA-42; SHEET; NMR; PATHOGENESIS;
D O I
10.1038/nsmb.1799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid-beta(1-42) (A beta 42) peptide rapidly aggregates to form oligomers, protofibils and fibrils en route to the deposition of amyloid plaques associated with Alzheimer's disease. We show that low-temperature and low-salt conditions can stabilize disc-shaped oligomers (pentamers) that are substantially more toxic to mouse cortical neurons than protofibrils and fibrils. We find that these neurotoxic oligomers do not have the beta-sheet structure characteristic of fibrils. Rather, the oligomers are composed of loosely aggregated strands whose C termini are protected from solvent exchange and which have a turn conformation, placing Phe19 in contact with Leu34. On the basis of NMR spectroscopy, we show that the structural conversion of A beta 42 oligomers to fibrils involves the association of these loosely aggregated strands into beta-sheets whose individual beta-strands polymerize in a parallel, in-register orientation and are staggered at an intermonomer contact between Gln15 and Gly37.
引用
收藏
页码:561 / U56
页数:8
相关论文
共 50 条
  • [41] α-synuclein induced synapse damage is enhanced by amyloid-β1-42
    Bate, Clive
    Gentleman, Steve
    Williams, Alun
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [42] In vitro fibrillization of Alzheimer's amyloid-β peptide (1-42)
    Tiiman, Ann
    Krishtal, Jekaterina
    Palumaa, Peep
    Tougu, Vello
    AIP ADVANCES, 2015, 5 (09):
  • [43] Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42
    Clive Bate
    Mario Salmona
    Alun Williams
    Journal of Neuroinflammation, 1
  • [44] Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
    Skillback, Tobias
    Farahmand, Bahman Y.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    BRAIN, 2015, 138 : 2716 - 2731
  • [45] Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42)
    Letoha, Tamas
    Hudak, Anett
    Kusz, Erzsebet
    Pettko-Szandtner, Aladar
    Domonkos, Ildiko
    Josvay, Katalin
    Hofmann-Apitius, Martin
    Szilak, Laszlo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] RRY Inhibits Amyloid-β1-42 Peptide Aggregation and Neurotoxicity
    Sun, Xicui
    Duan, Songwei
    Cao, Anna
    Villagomez, Bryan
    Lin, Runxuan
    Chen, Hongxia
    Pi, Liya
    Ren, Bin
    Chen, Rong
    Chen, Minjie
    Ying, Zhekang
    Fang, Shenyun
    Cao, Qi
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 479 - 495
  • [47] α-synuclein induced synapse damage is enhanced by amyloid-β1-42
    Clive Bate
    Steve Gentleman
    Alun Williams
    Molecular Neurodegeneration, 5
  • [48] VALPROIC ACID ENHANCES MICROGLIAL PHAGOCYTOSIS OF AMYLOID-β1-42
    Smith, A. M.
    Gibbons, H. M.
    Dragunow, M.
    NEUROSCIENCE, 2010, 169 (01) : 505 - 515
  • [49] Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid-β 1-42
    Vadukul, Devkee M.
    Gbajumo, Oyinkansola
    Marshall, Karen E.
    Serpell, Louise C.
    FEBS LETTERS, 2017, 591 (05) : 822 - 830
  • [50] Ginkgolide B inhibits the neurotoxicity of prions/amyloid-β1-42
    Bate, CAW
    Williams, A
    IMMUNOLOGY, 2005, 116 : 2 - 2